Fig. 2From: Qualitative interviews of patients with COPD and muscle weakness enrolled in a clinical trial evaluating a new anabolic treatment: patient perspectives of disease experience, trial participation and outcome assessmentsFeedback on 200182 trial outcome assessments during the 60-minute (n = 32) exit interviews. aParticipants provided more than one response so counts exceed totals. COPD, chronic obstructive pulmonary diseaseBack to article page